Biomutin 10% Premix 100 mg/g Premiks do sporządzania paszy leczniczej
Biomutin 10% Premix 100 mg/g Premiks do sporządzania paszy leczniczej
Authorised
- Tiamulin hydrogen fumarate
Product identification
Medicine name:
Biomutin 10% Premix 100 mg/g Premiks do sporządzania paszy leczniczej
Active substance:
- Tiamulin hydrogen fumarate
Target species:
-
Pig
Route of administration:
-
In-feed use
Product details
Active substance and strength:
-
Tiamulin hydrogen fumarate100.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Premix for medicated feeding stuff
Withdrawal period by route of administration:
-
In-feed use
-
Pig
-
Meat and offal11day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XQ01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Biowet Drwalew Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Drwalewskie Zaklady Przemyslu Bioweterynaryjnego S.A.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1199
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022